Related references
Note: Only part of the references are listed.Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway
Judith S. Sebolt-Leopold
CLINICAL CANCER RESEARCH (2008)
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Zhong Wang et al.
NATURE (2008)
The Histone H3K79 Methyltransferase Dot1L Is Essential for Mammalian Development and Heterochromatin Structure
Brendan Jones et al.
PLOS GENETICS (2008)
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment
M. C. Stubbs et al.
LEUKEMIA (2008)
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Dorothee Mueller et al.
BLOOD (2007)
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Piu Wong et al.
GENES & DEVELOPMENT (2007)
Hox genes in hematopoiesis and leukemogenesis
B. Argiropoulos et al.
ONCOGENE (2007)
Protein arginine-methyltransferase-dependent oncogenesis
Ngai Cheung et al.
NATURE CELL BIOLOGY (2007)
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias
Hiroshi Nakanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interaction of MLL amino terminal sequences with menin is required for transformation
Corrado Caslini et al.
CANCER RESEARCH (2007)
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling
Emmanuelle Bitoun et al.
HUMAN MOLECULAR GENETICS (2007)
Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations
Anastasia K. Yocum et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase
Mark D. Allen et al.
EMBO JOURNAL (2006)
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Tim C. P. Somervaille et al.
CANCER CELL (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner
P. Brown et al.
LEUKEMIA (2006)
Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation
Aline Mamo et al.
BLOOD (2006)
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent
R. Tonelli et al.
LEUKEMIA (2006)
Towards targeted therapy for infant acute lymphoblastic leukaemia
RW Stam et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia
RW Stam et al.
LEUKEMIA (2006)
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation
JJ Trowbridge et al.
NATURE MEDICINE (2006)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway
Q Yao et al.
LEUKEMIA (2005)
Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications
SM Huang et al.
GENES & DEVELOPMENT (2005)
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma
H Yasui et al.
BLOOD (2005)
The MLL partial tandem duplication:: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy
SP Whitman et al.
BLOOD (2005)
hDOT1L links histone methylation to leukemogenesis
Y Okada et al.
CELL (2005)
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
R Ono et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
TA Milne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression
P Brown et al.
BLOOD (2005)
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid
K Iijima et al.
LEUKEMIA & LYMPHOMA (2004)
Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9
CW So et al.
BLOOD (2004)
Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia
AR Kumar et al.
BLOOD (2004)
Menin associates with a trithorax family histone methyltransferase complex and with the Hoxc8 locus
CM Hughes et al.
MOLECULAR CELL (2004)
The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells
RS Srinivasan et al.
LEUKEMIA (2004)
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression
A Yokoyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein
PM Ayton et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
FLT3 mutations are associated with other molecular lesions in AML
MJ Carnicer et al.
LEUKEMIA RESEARCH (2004)
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization
BB Zeisig et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The small oligomerization domain of gephyrin converts MLL to an oncogene
M Eguchi et al.
BLOOD (2004)
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
PM Ayton et al.
GENES & DEVELOPMENT (2003)
Dimerization of MLL fusion proteins immortalizes hematopoietic cells
ME Martin et al.
CANCER CELL (2003)
Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias
CW So et al.
CANCER CELL (2003)
Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias:: dominance of HOX dysregulation
AA Ferrando et al.
BLOOD (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Structure of the catalytic domain of human DOT1L, a Non-SET domain nucleosomal histone methyltransferase
JR Min et al.
CELL (2003)
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia
RW Stam et al.
BLOOD (2003)
Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification
SA Armstrong et al.
CANCER CELL (2003)
Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain
Q Feng et al.
CURRENT BIOLOGY (2002)
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region
CH Pui et al.
LANCET (2002)
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
JF DiMartino et al.
BLOOD (2002)
The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation
M Birke et al.
NUCLEIC ACIDS RESEARCH (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality
T Rozovskaia et al.
ONCOGENE (2001)
Interferon α extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule
D Puthier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Sensitization by 5-aza-2′-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1α,25-dihydroxyvitamin D3
N Niitsu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Understanding Ras: 'it ain't over 'til it's over'
JM Shields et al.
TRENDS IN CELL BIOLOGY (2000)
Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia
C Lavau et al.
EMBO JOURNAL (2000)
Share Paper
